Melissa Lane, Cpa
About Melissa Lane, Cpa
Melissa Lane is a Senior Manager of Financial Planning and Analysis at OneOncology, with a background in accounting and finance. She holds a Bachelor of Business Administration from the University of Michigan and a Master's in Accounting from the University of Tennessee, Knoxville.
Current Role at OneOncology
Melissa Lane serves as the Senior Manager of Financial Planning and Analysis (FP&A) at OneOncology. She has held this position since 2021, contributing to the financial strategy and planning processes of the organization. Based in Nashville, Tennessee, her role involves overseeing financial performance, budgeting, and forecasting to support the company's operational goals.
Education and Expertise
Melissa Lane earned her Bachelor of Business Administration (BBA) in Accounting from the University of Michigan - Stephen M. Ross School of Business, completing her studies from 2010 to 2014. She furthered her education by obtaining a Master's in Accounting from the University of Tennessee, Knoxville, where she achieved a 4.0 GPA from 2014 to 2015. Her academic background provides her with a strong foundation in financial principles and practices.
Professional Background
Melissa Lane has a diverse professional background in financial planning and analysis. She began her career as an Audit Intern at Deloitte in 2013. Afterward, she worked as an Audit Associate at Deloitte from 2015 to 2018. She then joined NDC, Inc., where she held various roles, including Senior Financial Analyst, Financial Planning and Analysis Manager, and Director of Financial Planning and Analysis before transitioning to her current role at OneOncology.
Career Progression
Melissa Lane's career progression reflects her expertise in financial analysis and management. After her initial role at Deloitte, she advanced to NDC, Inc., where she spent three years as an Audit Associate and later took on roles that included Senior Financial Analyst and Financial Planning and Analysis Manager. She was promoted to Director of Financial Planning and Analysis for a brief period in 2021 before joining OneOncology.